<p>Hierarchical clustering was used to divide six large breast cancer patient cohorts into high vs. low Met kinetic signature. Kaplan Meier analysis of overall survival (A,B,C,D,E) and metastasis-free survival (F,G) of the Chang (A, F, H, I), Miller (B), GSE1456 (C), GSE3165 (D), GSE11121 (E) and van ‘t veer (G) data sets. Kaplan Meier analysis of overall survival (H) and metastasis-free survival (I) of stage-I patients in the Chang data set. A red line denotes patients with high Met kinetic signature and a blue line denotes patients with low Met kinetic signature. In Chang data set, Met kinetic signature has a positive predictive value (PPV) and negative predictive value (NPV) of 41% and 82%, respectively.</p
<p>A: among all breast cancer patients; B: among patients without lymph node metastasis; C: among pa...
<p>(A) Cells from six human breast cancer cell lines (MDA231, Hs578T, BT549, MCF10, MCF7 and T47D) w...
<p>Patients were stratified by high (n=45) and low (n=57) PCNA<sup>+</sup> TAMs. The difference bet...
<p>Hierarchical clustering was used to divide three large breast cancer patient cohorts (Chang (A), ...
<p>Kaplan-Meier survival curves of patients grouped in the 10 clusters show significant survival dif...
<p> <b>A.</b> Predicted outcomes in NKI test set (148 patients). Kaplan-Meier p...
From a compendium of four breast cancer datasets (from GEO: GSE-2603, GSE2034, GSE5327, GSE12276). T...
<p>181 patients from the HumanMethylation27 BeadChip Cohort had the appropriate clinical data.</p
<p>Kaplan-Meier plots showing time of overall survival (OS) and relapse-free survival (RFS) of breas...
<p>145 patients from the HumanMethylation450 BeadChip Cohort had the appropriate clinical data.</p
<p>Kaplan-Meier estimates of breast cancer-specific survival (A) and recurrence/metastasis-free surv...
<p> <b>A.</b> Unsupervised cluster analysis of NKI training data set (147 sampl...
<p>Kaplan-Meier survival and cox regression analysis of clinicopathological characteristics on 5- ye...
<p>Kaplan-Meier survival analysis of a second independent validation patient cohort consisting of 12...
<p>(A) Kaplan-Meier curves for RFS comparing patients with a high PCNA<sup>+</sup> TAMs surrogate sc...
<p>A: among all breast cancer patients; B: among patients without lymph node metastasis; C: among pa...
<p>(A) Cells from six human breast cancer cell lines (MDA231, Hs578T, BT549, MCF10, MCF7 and T47D) w...
<p>Patients were stratified by high (n=45) and low (n=57) PCNA<sup>+</sup> TAMs. The difference bet...
<p>Hierarchical clustering was used to divide three large breast cancer patient cohorts (Chang (A), ...
<p>Kaplan-Meier survival curves of patients grouped in the 10 clusters show significant survival dif...
<p> <b>A.</b> Predicted outcomes in NKI test set (148 patients). Kaplan-Meier p...
From a compendium of four breast cancer datasets (from GEO: GSE-2603, GSE2034, GSE5327, GSE12276). T...
<p>181 patients from the HumanMethylation27 BeadChip Cohort had the appropriate clinical data.</p
<p>Kaplan-Meier plots showing time of overall survival (OS) and relapse-free survival (RFS) of breas...
<p>145 patients from the HumanMethylation450 BeadChip Cohort had the appropriate clinical data.</p
<p>Kaplan-Meier estimates of breast cancer-specific survival (A) and recurrence/metastasis-free surv...
<p> <b>A.</b> Unsupervised cluster analysis of NKI training data set (147 sampl...
<p>Kaplan-Meier survival and cox regression analysis of clinicopathological characteristics on 5- ye...
<p>Kaplan-Meier survival analysis of a second independent validation patient cohort consisting of 12...
<p>(A) Kaplan-Meier curves for RFS comparing patients with a high PCNA<sup>+</sup> TAMs surrogate sc...
<p>A: among all breast cancer patients; B: among patients without lymph node metastasis; C: among pa...
<p>(A) Cells from six human breast cancer cell lines (MDA231, Hs578T, BT549, MCF10, MCF7 and T47D) w...
<p>Patients were stratified by high (n=45) and low (n=57) PCNA<sup>+</sup> TAMs. The difference bet...